nodes	percent_of_prediction	percent_of_DWPC	metapath
Quazepam—GABRA3—Graves' disease	0.718	1	CbGaD
Quazepam—CYP2C19—Methimazole—Graves' disease	0.0845	0.432	CbGbCtD
Quazepam—CYP2C9—Methimazole—Graves' disease	0.0702	0.359	CbGbCtD
Quazepam—CYP3A4—Methimazole—Graves' disease	0.0408	0.209	CbGbCtD
Quazepam—GABRG3—GABA A receptor activation—GABRA3—Graves' disease	0.00375	0.0521	CbGpPWpGaD
Quazepam—GABRB1—GABA A receptor activation—GABRA3—Graves' disease	0.00369	0.0514	CbGpPWpGaD
Quazepam—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.00306	0.0426	CbGpPWpGaD
Quazepam—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00296	0.0411	CbGpPWpGaD
Quazepam—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.00294	0.0409	CbGpPWpGaD
Quazepam—GABRR1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00292	0.0406	CbGpPWpGaD
Quazepam—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00288	0.0401	CbGpPWpGaD
Quazepam—GABRR2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00279	0.0388	CbGpPWpGaD
Quazepam—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.00252	0.0351	CbGpPWpGaD
Quazepam—GABRG3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00229	0.0319	CbGpPWpGaD
Quazepam—GABRB1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00226	0.0314	CbGpPWpGaD
Quazepam—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00188	0.0261	CbGpPWpGaD
Quazepam—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00181	0.0252	CbGpPWpGaD
Quazepam—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0018	0.025	CbGpPWpGaD
Quazepam—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00177	0.0246	CbGpPWpGaD
Quazepam—GABRR1—GABA receptor activation—GABRA3—Graves' disease	0.00155	0.0216	CbGpPWpGaD
Quazepam—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00154	0.0215	CbGpPWpGaD
Quazepam—GABRR2—GABA receptor activation—GABRA3—Graves' disease	0.00148	0.0206	CbGpPWpGaD
Quazepam—GABRG3—GABA receptor activation—GABRA3—Graves' disease	0.00122	0.0169	CbGpPWpGaD
Quazepam—GABRB1—GABA receptor activation—GABRA3—Graves' disease	0.0012	0.0167	CbGpPWpGaD
Quazepam—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.000995	0.0138	CbGpPWpGaD
Quazepam—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.00096	0.0134	CbGpPWpGaD
Quazepam—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.000954	0.0133	CbGpPWpGaD
Quazepam—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.000937	0.013	CbGpPWpGaD
Quazepam—GABRR3—eye—Graves' disease	0.000851	0.129	CbGeAlD
Quazepam—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.000819	0.0114	CbGpPWpGaD
Quazepam—GABRR2—eye—Graves' disease	0.000738	0.112	CbGeAlD
Quazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000712	0.00991	CbGpPWpGaD
Quazepam—GABRR1—eye—Graves' disease	0.00071	0.108	CbGeAlD
Quazepam—GABRG3—Orphan transporters—GABRA3—Graves' disease	0.00071	0.00988	CbGpPWpGaD
Quazepam—GABRB1—Orphan transporters—GABRA3—Graves' disease	0.000699	0.00973	CbGpPWpGaD
Quazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00068	0.00946	CbGpPWpGaD
Quazepam—Clonazepam—GABRA3—Graves' disease	0.000653	0.0903	CrCbGaD
Quazepam—GABRR1—Ion channel transport—GABRA3—Graves' disease	0.000634	0.00882	CbGpPWpGaD
Quazepam—Clotiazepam—GABRA3—Graves' disease	0.000606	0.0839	CrCbGaD
Quazepam—GABRR2—Ion channel transport—GABRA3—Graves' disease	0.000605	0.00841	CbGpPWpGaD
Quazepam—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.00058	0.00808	CbGpPWpGaD
Quazepam—Alprazolam—GABRA3—Graves' disease	0.000572	0.0792	CrCbGaD
Quazepam—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.00056	0.00779	CbGpPWpGaD
Quazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00056	0.00779	CbGpPWpGaD
Quazepam—Cinolazepam—GABRA3—Graves' disease	0.000558	0.0772	CrCbGaD
Quazepam—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.000556	0.00774	CbGpPWpGaD
Quazepam—GABRG3—pituitary gland—Graves' disease	0.000553	0.0842	CbGeAlD
Quazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000551	0.00767	CbGpPWpGaD
Quazepam—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000546	0.0076	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000535	0.00745	CbGpPWpGaD
Quazepam—Flunitrazepam—GABRA3—Graves' disease	0.000524	0.0725	CrCbGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000511	0.00711	CbGpPWpGaD
Quazepam—GABRG3—Ion channel transport—GABRA3—Graves' disease	0.000498	0.00693	CbGpPWpGaD
Quazepam—GABRB1—Ion channel transport—GABRA3—Graves' disease	0.00049	0.00682	CbGpPWpGaD
Quazepam—Estazolam—GABRA3—Graves' disease	0.00049	0.0678	CrCbGaD
Quazepam—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.000478	0.00665	CbGpPWpGaD
Quazepam—Halazepam—GABRA3—Graves' disease	0.000476	0.0659	CrCbGaD
Quazepam—Adinazolam—GABRA3—Graves' disease	0.000466	0.0646	CrCbGaD
Quazepam—Fludiazepam—GABRA3—Graves' disease	0.000462	0.064	CrCbGaD
Quazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000458	0.00637	CbGpPWpGaD
Quazepam—Prazepam—GABRA3—Graves' disease	0.000451	0.0624	CrCbGaD
Quazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000442	0.00614	CbGpPWpGaD
Quazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000439	0.0061	CbGpPWpGaD
Quazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000431	0.00599	CbGpPWpGaD
Quazepam—GABRB1—pituitary gland—Graves' disease	0.000428	0.0651	CbGeAlD
Quazepam—GABRG3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000421	0.00585	CbGpPWpGaD
Quazepam—Flurazepam—GABRA3—Graves' disease	0.000421	0.0582	CrCbGaD
Quazepam—Triazolam—GABRA3—Graves' disease	0.00042	0.0581	CrCbGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000414	0.00577	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—GABRA3—Graves' disease	0.00041	0.00571	CbGpPWpGaD
Quazepam—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.000407	0.00567	CbGpPWpGaD
Quazepam—Temazepam—GABRA3—Graves' disease	0.000402	0.0556	CrCbGaD
Quazepam—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000393	0.00547	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—GABRA3—Graves' disease	0.000391	0.00545	CbGpPWpGaD
Quazepam—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.00039	0.00543	CbGpPWpGaD
Quazepam—Midazolam—GABRA3—Graves' disease	0.00039	0.054	CrCbGaD
Quazepam—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000383	0.00533	CbGpPWpGaD
Quazepam—GABRP—pituitary gland—Graves' disease	0.000383	0.0583	CbGeAlD
Quazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000377	0.00524	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000344	0.00479	CbGpPWpGaD
Quazepam—GABRA3—thyroid gland—Graves' disease	0.000341	0.0519	CbGeAlD
Quazepam—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000335	0.00466	CbGpPWpGaD
Quazepam—Diazepam—GABRA3—Graves' disease	0.000334	0.0462	CrCbGaD
Quazepam—GABRB3—eye—Graves' disease	0.000334	0.0508	CbGeAlD
Quazepam—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000332	0.00462	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00033	0.00459	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000324	0.00451	CbGpPWpGaD
Quazepam—GABRG2—pituitary gland—Graves' disease	0.000323	0.0491	CbGeAlD
Quazepam—GABRG3—Neuronal System—GABRA3—Graves' disease	0.000322	0.00449	CbGpPWpGaD
Quazepam—GABRB3—connective tissue—Graves' disease	0.000322	0.0489	CbGeAlD
Quazepam—GABRB1—Neuronal System—GABRA3—Graves' disease	0.000317	0.00442	CbGpPWpGaD
Quazepam—GABRA2—adipose tissue—Graves' disease	0.000294	0.0447	CbGeAlD
Quazepam—GABRE—pituitary gland—Graves' disease	0.000292	0.0445	CbGeAlD
Quazepam—GABRE—adipose tissue—Graves' disease	0.000291	0.0443	CbGeAlD
Quazepam—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000283	0.00394	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—GABRA3—Graves' disease	0.000264	0.00367	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—GABRA3—Graves' disease	0.000254	0.00354	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—GABRA3—Graves' disease	0.000253	0.00352	CbGpPWpGaD
Quazepam—GABRE—thyroid gland—Graves' disease	0.000252	0.0383	CbGeAlD
Quazepam—GABRG2—Neuronal System—GABRA3—Graves' disease	0.000248	0.00345	CbGpPWpGaD
Quazepam—GABRB3—pituitary gland—Graves' disease	0.000248	0.0377	CbGeAlD
Quazepam—GABRR1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000221	0.00307	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000217	0.00302	CbGpPWpGaD
Quazepam—GABRB3—thyroid gland—Graves' disease	0.000214	0.0325	CbGeAlD
Quazepam—GABRR2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00021	0.00293	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000173	0.00241	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000171	0.00238	CbGpPWpGaD
Quazepam—Drowsiness—Methimazole—Graves' disease	0.000158	0.214	CcSEcCtD
Quazepam—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000142	0.00197	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000137	0.0019	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000136	0.00189	CbGpPWpGaD
Quazepam—Drowsiness—Propylthiouracil—Graves' disease	0.000134	0.182	CcSEcCtD
Quazepam—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000133	0.00186	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000117	0.00162	CbGpPWpGaD
Quazepam—Somnolence—Methimazole—Graves' disease	8.95e-05	0.121	CcSEcCtD
Quazepam—Dyspepsia—Methimazole—Graves' disease	8.86e-05	0.12	CcSEcCtD
Quazepam—Somnolence—Propylthiouracil—Graves' disease	7.61e-05	0.103	CcSEcCtD
Quazepam—Dyspepsia—Propylthiouracil—Graves' disease	7.53e-05	0.102	CcSEcCtD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	6.78e-05	0.000943	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—GC—Graves' disease	6.78e-05	0.000943	CbGpPWpGaD
Quazepam—Headache—Methimazole—Graves' disease	6.31e-05	0.0854	CcSEcCtD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—GC—Graves' disease	6.18e-05	0.00086	CbGpPWpGaD
Quazepam—Headache—Propylthiouracil—Graves' disease	5.36e-05	0.0726	CcSEcCtD
Quazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	4.92e-05	0.000685	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GC—Graves' disease	3.02e-05	0.00042	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GC—Graves' disease	2.75e-05	0.000383	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—B3GNT2—Graves' disease	2.29e-05	0.000318	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—B3GNT2—Graves' disease	2.09e-05	0.00029	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GC—Graves' disease	1.82e-05	0.000253	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.38e-05	0.000191	CbGpPWpGaD
